Recurrent SARS-CoV-2 mutations at Spike D796 evade antibodies from pre-Omicron convalescent and vaccinated subjects
E. A. Elko, H. Mead, G. A. Nelson, J. Zaia, J. T. Ladner, J. A. Altin
The paper shows that SARS-CoV-2 mutations at Spike D796 (D796Y and D796H) evade antibodies from pre-Omicron convalescent and vaccinated individuals.
Microbiology Spectrum · Feb 6, 2024Peer-reviewedImmunology